Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Older and younger adults surf different brain waves

  • Persistent ADHD associated with overly critical parents

  • Using medical marijuana to stop seizures in kids

  • Millennials say one thing but do another when choosing chocolate

  • New device to get people with paralysis back on their feet

  • Research finds no easy answers to use of drug screening for pain patients

  • Brain scars in multiple sclerosis patients reveal possible cause of taste problems

  • Wbp2 is a novel deafness gene

  • New wireless sleeve to help people recover arm use after stroke

  • Wirelessly supplying power to brain

  •